Romiplostim in adults with newly diagnosed or persistent immune thrombocytopenia
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Romiplostim in adults with newly diagnosed or persistent immune thrombocytopenia
Authors
Keywords
-
Journal
Expert Review of Hematology
Volume 13, Issue 12, Pages 1319-1332
Publisher
Informa UK Limited
Online
2020-11-30
DOI
10.1080/17474086.2020.1850253
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reference guide for management of adult immune thrombocytopenia in Japan: 2019 Revision
- (2020) Hirokazu Kashiwagi et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Assessment of romiplostim immunogenicity in adult patients in clinical trials and in a global postmarketing registry
- (2020) Daniel T. Mytych et al. BRITISH JOURNAL OF HAEMATOLOGY
- Treatment Patterns Among Adults with Primary Immune Thrombocytopenia Diagnosed in Hematology Clinics in the United States
- (2020) Leah J McGrath et al. Clinical Epidemiology
- Primary immune thrombocytopenia (ITP) treated with romiplostim in routine clinical practice: retrospective study from the United Kingdom ITP Registry
- (2019) Indraraj Umesh Doobaree et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Romiplostim in adult patients with newly diagnosed or persistent immune thrombocytopenia (ITP) for up to 1 year and in those with chronic ITP for more than 1 year: a subgroup analysis of integrated data from completed romiplostim studies
- (2019) David J. Kuter et al. BRITISH JOURNAL OF HAEMATOLOGY
- Thrombopoietin receptor agonists: Ten Years Later
- (2019) Waleed Ghanima et al. HAEMATOLOGICA
- Health-Related Quality of Life and Burden of Fatigue in Chinese Patients with Immune Thrombocytopenia: A Cross-Sectional Study
- (2019) Ran Yang et al. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
- Thrombopoietin receptor agonist (TPO-RA) treatment raises platelet counts and reduces anti-platelet antibody levels in mice with immune thrombocytopenia (ITP)
- (2019) Rick Kapur et al. PLATELETS
- Immunomodulation in Primary Immune Thrombocytopenia: A Possible Role of the Fc Fragment of Romiplostim?
- (2019) Alexandra Schifferli et al. Frontiers in Immunology
- Eltrombopag for Immune Thrombocytopenia Adult Patients in the Real-Life Practice in France. Interim Results of the Elextra Study
- (2019) Guillaume Moulis et al. BLOOD
- Effectiveness of Romiplostim for Treatment of Adults with Newly Diagnosed or Persistent Primary Immune Thrombocytopenia in US Clinical Practice
- (2019) Mark Hatfield et al. BLOOD
- Updated Results from the Single-Arm, Open-Label, Long-Term Efficacy and Safety Study of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)
- (2019) John Grainger et al. BLOOD
- Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia
- (2019) Maria L. Lozano et al. Scientific Reports
- Treatment characteristics, efficacy and safety of thrombopoietin analogues in routine management of primary immune thrombocytopenia
- (2018) María E. Mingot-Castellano et al. BLOOD COAGULATION & FIBRINOLYSIS
- A critical appraisal of the evidence for the role of splenectomy in adults and children with ITP
- (2018) Francesco Rodeghiero BRITISH JOURNAL OF HAEMATOLOGY
- A Randomized Multicenter Trial Comparing Low-Dose Prednisolone Versus Observation for Prevention of Recurrences in Adult Immune Thrombocytopenia
- (2018) Arunrat Pirunsarn et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Thrombopoietin receptor agonists in patients with persistent or chronic immune thrombocytopenia
- (2018) Jacopo Agnelli Giacchello et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Emerging Concepts in Immune Thrombocytopenia
- (2018) Maurice Swinkels et al. Frontiers in Immunology
- Adverse Effects of Immunoglobulin Therapy
- (2018) Yi Guo et al. Frontiers in Immunology
- Initial romiplostim dosing and time to platelet response in patients with treatment refractory immune thrombocytopenia
- (2018) Ryan K DasGupta et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Immune Thrombocytopenia - Current Diagnostics and Therapy: Recommendations of a Joint Working Group of DGHO, ÖGHO, SGH, GPOH, and DGTI
- (2018) Axel Matzdorff et al. Oncology Research and Treatment
- Health-related quality of life in adult primary immune thrombocytopenia
- (2018) Hanna Gran Sestøl et al. Expert Review of Hematology
- Bleeding tendency and platelet function during treatment with romiplostim in children with severe immune thrombocytopenic purpura
- (2017) Elena V. Suntsova et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice
- (2017) Tomás José González-López et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Thrombopoietin receptor agonists in conjunction with oseltamivir for immune thrombocytopenia
- (2016) María T. Álvarez-Román et al. AIDS
- Depression in adult patients with primary immune thrombocytopenia
- (2016) Deirdra R. Terrell et al. AMERICAN JOURNAL OF HEMATOLOGY
- Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study
- (2016) Francesco Zaja et al. AMERICAN JOURNAL OF HEMATOLOGY
- Tolerability and Efficacy of Eltrombopag in Chronic Immune Thrombocytopenia: Meta-Analysis of Randomized Controlled Trials
- (2016) Ahmed Saber Elgebaly et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- TPO-RAs in pITP: description of a case series and analysis of predictive factors for response
- (2016) Maria Gabriella Mazzucconi et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Response loss and development of neutralizing antibodies during long-term treatment with romiplostim in patients with immune thrombocytopenia: a case series
- (2016) Monica Carpenedo et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- A large observational study of patients with primary immune thrombocytopenia receiving romiplostim in European clinical practice
- (2016) Michael Steurer et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Remissions after long-term use of romiplostim for immune thrombocytopenia
- (2016) A. L. Marshall et al. HAEMATOLOGICA
- Immune thrombocytopenia in adults: a prospective cohort study of clinical features and predictors of outcome
- (2016) L. Grimaldi-Bensouda et al. HAEMATOLOGICA
- Successful early romiplostim use in a case of severe immune thrombocytopenia with critical carotid arterial injury
- (2016) Reiko Watanabe et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Thrombopoietin Receptor Agonist Use in Children: Data From the Pediatric ITP Consortium of North America ICON2 Study
- (2016) Cindy Neunert et al. PEDIATRIC BLOOD & CANCER
- Remissions after long-term use of romiplostim for immune thrombocytopenia
- (2016) A. L. Marshall et al. HAEMATOLOGICA
- Immune thrombocytopenia in adults: a prospective cohort study of clinical features and predictors of outcome
- (2016) L. Grimaldi-Bensouda et al. HAEMATOLOGICA
- Romiplostim Treatment in Adults with Immune Thrombocytopenia of Varying Duration and Severity
- (2015) Ann Janssens et al. ACTA HAEMATOLOGICA
- Is ITP a thrombophilic disorder?
- (2015) Francesco Rodeghiero AMERICAN JOURNAL OF HEMATOLOGY
- Fatigue in immune thrombocytopenia
- (2015) Quentin A. Hill et al. BRITISH JOURNAL OF HAEMATOLOGY
- Risk of arterial thrombotic and venous thromboembolic events in patients with primary chronic immune thrombocytopenia: a Scandinavian population-based cohort study
- (2015) Mette Nørgaard et al. BRITISH JOURNAL OF HAEMATOLOGY
- Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study
- (2015) Adrian Newland et al. BRITISH JOURNAL OF HAEMATOLOGY
- Integrated analysis of long-term safety in patients with chronic immune thrombocytopaenia (ITP) treated with the thrombopoietin (TPO) receptor agonist romiplostim
- (2015) Douglas B. Cines et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review
- (2015) C. Neunert et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Can Immune Thrombocytopenia Be Cured with Medical Therapy?
- (2015) Eline Prak et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: A study among a U.S. cohort of commercial insurance enrollees
- (2015) Hussain R. Yusuf et al. THROMBOSIS RESEARCH
- Regulation of Immune Responses by the Neonatal Fc Receptor and Its Therapeutic Implications
- (2015) Timo Rath et al. Frontiers in Immunology
- Eltrombopag and high-dose dexamethasone as frontline treatment of newly diagnosed immune thrombocytopenia in adults
- (2014) D. Gomez-Almaguer et al. BLOOD
- The temporary use of thrombopoietin-receptor agonists may induce a prolonged remission in adult chronic immune thrombocytopenia. Results of a French observational study
- (2014) Matthieu Mahévas et al. BRITISH JOURNAL OF HAEMATOLOGY
- Twenty-year mortality of adult patients with primary immune thrombocytopenia: a Danish population-based cohort study
- (2014) Henrik Frederiksen et al. BRITISH JOURNAL OF HAEMATOLOGY
- Tregitope: Immunomodulation Powerhouse
- (2014) Leslie Cousens et al. HUMAN IMMUNOLOGY
- Thrombopoietin receptor agonists in immune thrombocytopenia of less than 6 months duration
- (2014) A. Arumugaswamy et al. INTERNAL MEDICINE JOURNAL
- Eltrombopag therapy in newly diagnosed steroid non-responsive ITP patients
- (2014) Anil Kumar Tripathi et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Thrombopoietic Agents for the Treatment of Persistent and Chronic Immune Thrombocytopenia in Children
- (2014) Kavitha Ramaswamy et al. JOURNAL OF PEDIATRICS
- ITP and international guidelines: What do we know, what do we need?
- (2014) Francesco Rodeghiero et al. PRESSE MEDICALE
- Thrombopoietin levels in patients with disorders of platelet production: Diagnostic potential and utility in predicting response to TPO Receptor agonists
- (2013) Robert S. Makar et al. AMERICAN JOURNAL OF HEMATOLOGY
- Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia
- (2013) S. Boyle et al. BLOOD
- Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy
- (2013) David J. Kuter et al. BRITISH JOURNAL OF HAEMATOLOGY
- Successful Treatment of Severe Newly Diagnosed Immune Thrombocytopenia Involving an Alveolar Hemorrhage with Combination Therapy Consisting of Romiplostim, Rituximab and Vincristine
- (2013) Kiyoshi Okazuka et al. INTERNAL MEDICINE
- Romiplostim as early treatment for refractory primary immune thrombocytopenia
- (2013) Anne Contis et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Health-related quality of life in nonsplenectomized immune thrombocytopenia patients receiving romiplostim or medical standard of care
- (2012) David J. Kuter et al. AMERICAN JOURNAL OF HEMATOLOGY
- Immune thrombocytopenia and anticoagulation: the role of romiplostim in the early treatment
- (2012) Nathan Cantoni et al. BRITISH JOURNAL OF HAEMATOLOGY
- Absence of bi-directional cross-resistance of thrombopoietin receptor agonists in chronic refractory immune thrombocytopenia: possible role ofMPLpolymorphisms
- (2012) Nicola Polverelli et al. BRITISH JOURNAL OF HAEMATOLOGY
- Use of Romiplostim for Primary Immune Thrombocytopenia in Children
- (2012) Vicente Escudero Vilaplana et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
- (2011) C. Neunert et al. BLOOD
- Romiplostim for the early management of severe immune thrombocytopenia unresponsive to conventional treatment
- (2011) Giuseppe Tagariello et al. BRITISH JOURNAL OF HAEMATOLOGY
- Analysis of EQ-5D scores from two phase 3 clinical trials of romiplostim in the treatment of immune thrombocytopenia (ITP)
- (2011) Miguel A. Sanz et al. VALUE IN HEALTH
- Epidemiology of paediatric immune thrombocytopenia in the General Practice Research Database
- (2010) Mellissa Yong et al. BRITISH JOURNAL OF HAEMATOLOGY
- Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database
- (2010) A. Sarpatwari et al. HAEMATOLOGICA
- Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia
- (2010) David J. Kuter et al. NEW ENGLAND JOURNAL OF MEDICINE
- FATIGUE AS MARKER OF THROMBOCYTOPENIA IN CHILDHOOD IDIOPATHIC THROMBOCYTOPENIC PURPURA
- (2010) Julie Blatt et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- Biology and Chemistry of Thrombopoietic Agents
- (2010) David J. Kuter SEMINARS IN HEMATOLOGY
- Evaluating clinically meaningful change on the ITP-PAQ: preliminary estimates of minimal important differences
- (2009) Susan D. Mathias et al. CURRENT MEDICAL RESEARCH AND OPINION
- Corticosteroid side-effects and risk for bleeding in immune thrombocytopenic purpura: patient and hematologist perspectives
- (2009) Jacqueline A. Guidry et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- The incidence of idiopathic thrombocytopenic purpura among adults: a population-based study and literature review
- (2009) Page E. Abrahamson et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP
- (2008) J. B. Bussel et al. BLOOD
- Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
- (2008) F. Rodeghiero et al. BLOOD
- Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials
- (2008) James N. George et al. BRITISH JOURNAL OF HAEMATOLOGY
- Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
- (2008) David J Kuter et al. LANCET
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started